You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 19, October 25, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (70)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Obesity
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults

Hae Jin Kim, MD; Hyeong Jin Kim, MD; Kwang Eun Lee, MD; Dae Jung Kim, MD; Soo Kyung Kim, MD; Chul Woo Ahn, MD, PhD; Sung-Kil Lim, MD, PhD; Kyung Rae Kim, MD, PhD; Hyun Chul Lee, MD, PhD; Kap Bum Huh, MD, PhD; Bong Soo Cha, MD, PhD

Arch Intern Med. 2004;164:2169-2175.

Background  Obesity and type 2 diabetes are well-known risk factors for the development of nonalcoholic fatty liver disease (NAFLD). However, NAFLD is not rare in nonobese, nondiabetic adults. The aim of this study was to evaluate the metabolic significance of NAFLD in nonobese, nondiabetic adults.

Methods  This study examined 768 nonobese (body mass index [BMI] [calculated as weight in kilograms divided by the square of height in meters], ≥18.5 and <30) (460 normal-weight and 308 overweight subjects), nondiabetic individuals older than 30 years who participated in a medical checkup. All the subjects had negative serologic findings for hepatitis B and C viruses and had an alcohol intake less than 140 g/wk. A standard interview, anthropometrics, a biochemical study, and abdominal ultrasonography were conducted.

Results  The prevalence of NAFLD in the enrolled subjects was 23.4%. In the normal-weight (BMI, ≥18.5 and <25) and overweight (BMI, ≥25 and <30) groups, NAFLD was a significant predictor of insulin resistance and other metabolic disorders, including hypertriglyceridemia and hyperuricemia. The odds ratio of the metabolic disorders in subjects with NAFLD compared with those without NAFLD in the normal-weight groupwashigher than that in the overweight group. Multiplelogisticregression analysis showed that sex, waist circumference, triglyceride level, and insulin resistance wereindependentlyassociated with NAFLD in the normal-weight group.

Conclusions  Nonalcoholic fatty liver disease is closely associated with metabolic disorders, even in nonobese, nondiabetic subjects. Nonalcoholic fatty liver disease can be considered an early predictor of metabolic disorders, particularly in the normal-weight population.


Author Affiliations: Division of Endocrinology and Metabolism, Department of Internal Medicine (Drs Hae J. Kim, K. E. Lee, S. K. Kim, Ahn, Lim, K. R. Kim, H. C. Lee, Huh, and Cha), and the Brain Korea 21 Project for Medical Science (Drs Lim, K. R. Kim, H. C. Lee, and Cha), Yonsei University College of Medicine, Seoul, Korea; Department of Internal Medicine, Kwan Dong University College of Medicine, Goyang, Korea (Dr Hyeong J. Kim); and Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea (Dr D. J. Kim).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Asians Need Different Criteria for Defining Overweight and Obesity
Radha K. Dhiman, Ajay Duseja, and Yogesh Chawla
Arch Intern Med. 2005;165(9):1069-1070.
EXTRACT | FULL TEXT  

Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver Disease
Luca Mascitelli and Francesca Pezzetta
Arch Intern Med. 2005;165(9):1070.
EXTRACT | FULL TEXT  

Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver Disease—Reply
Hae Jin Kim, Soo Kyung Kim, and Bong Soo Cha
Arch Intern Med. 2005;165(9):1070.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men
Chang et al.
Gut 2009;58:1419-1425.
ABSTRACT | FULL TEXT  

Causes and Metabolic Consequences of Fatty Liver
Stefan et al.
Endocr. Rev. 2008;29:939-960.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome
Cornier et al.
Endocr. Rev. 2008;29:777-822.
ABSTRACT | FULL TEXT  

Nonalcoholic Fatty Liver Disease in Children
Manco et al.
J. Am. Coll. Nutr. 2008;27:667-676.
ABSTRACT | FULL TEXT  

Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance
Choi et al.
J. Biol. Chem. 2007;282:22678-22688.
ABSTRACT | FULL TEXT  

Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Zivkovic et al.
Am. J. Clin. Nutr. 2007;86:285-300.
ABSTRACT | FULL TEXT  

Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat
Erhuma et al.
Am. J. Physiol. Endocrinol. Metab. 2007;292:E1702-E1714.
ABSTRACT | FULL TEXT  

Influence of Hepatic Steatosis (Fatty Liver) on Severity and Composition of Dyslipidemia in Type 2 Diabetes
Toledo et al.
Diabetes Care 2006;29:1845-1850.
ABSTRACT | FULL TEXT  

Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver Disease
Mascitelli and Pezzetta
Arch Intern Med 2005;165:1070-1070.
FULL TEXT  

Asians Need Different Criteria for Defining Overweight and Obesity
Dhiman et al.
Arch Intern Med 2005;165:1069-1070.
FULL TEXT  

Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver Disease--Reply
Kim et al.
Arch Intern Med 2005;165:1070-1070.
FULL TEXT  

Nonalcoholic fatty liver disease
Adams et al.
CMAJ 2005;172:899-905.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.